Related Experiment Video

Updated: Sep 21, 2026

Mutagenesis and Functional Analysis of Ion Channels Heterologously Expressed in Mammalian Cells
15:28

Mutagenesis and Functional Analysis of Ion Channels Heterologously Expressed in Mammalian Cells

Published on: October 1, 2010

Signal transduction by several KIT juxtamembrane domain mutations

Nathalie Casteran1, Paulo De Sepulveda, Nathalie Beslu

  • 1Molecular and Functional Hematopoiesis Laboratory, U119 INSERM, 27 Bd Leï Roure 13009 Marseille, France.

Oncogene
|July 25, 2003
PubMed

Insights

A new KIT juxtamembrane domain (JMD) mutation, Kdelta27, drives cancer by causing constitutive activation of signaling pathways. This oncogenic KIT mutation is a potential therapeutic target for mastocytosis and GISTs.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Mutations in the KIT receptor tyrosine kinase are prevalent in mastocytosis and gastrointestinal stromal tumors (GISTs).
  • KIT juxtamembrane domain (JMD) mutations are common in GISTs, while kinase domain mutations occur in systemic mastocytosis.

Purpose of the Study:

  • To characterize a novel KIT-JMD mutation, Kdelta27.
  • To investigate the functional consequences of Kdelta27 on KIT signaling and cellular behavior.

Main Methods:

  • Ectopic expression of Kdelta27 in Ba/F3 cells and primary bone marrow mast cells.
  • Analysis of KIT dimerization, phosphorylation, and downstream signaling pathways.
  • In vitro kinase assays and drug sensitivity testing.

Main Results:

  • Kdelta27 exhibits constitutive dimerization and phosphorylation, leading to cytokine-independent proliferation and survival.
  • Kdelta27 activates classical KIT signaling pathways, with altered substrate specificity and preferential STAT protein phosphorylation.
  • KIT kinase inhibitors demonstrate greater efficacy against JMD mutations compared to wild-type KIT.

Conclusions:

  • Kdelta27 is a novel oncogenic KIT mutation causing constitutive activation of downstream signaling.
  • Oncogenic KIT mutations, particularly JMD mutations, display distinct signaling profiles and drug sensitivities.
  • Specific signaling pathways are preferentially activated by oncogenic KIT, offering potential therapeutic strategies.

More Related Videos

Transmembrane Domain Oligomerization Propensity determined by ToxR Assay06:45

Transmembrane Domain Oligomerization Propensity determined by ToxR Assay

Published on: May 26, 2011

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...